Acadia Pharmaceuticals Inc. (ACAD)

Last Three Months

29-Jun-23 -- 28-Sep-23

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Buy

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

3

(1)

30

0

0

+1

0

+2

0

+3

Two Year Chart

29-Sep-21 -- 28-Sep-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
18-Jul-23 6:00 PM View:	14-Jul-23 Planned Private Option Sale ($3.00M)	Davis Stephen CEO Director		Acadia Pharmaceuticals Inc. - ACAD	(66%) 108.3K to 36.7K	0	0	--	--	Show Txns Hide Txns

19-Sep-23 6:31 PM View:	15-Sep-23 Private Sale (Planned) ($51.76K)	Kihara James Principal Accounting Officer		Acadia Pharmaceuticals Inc. - ACAD	(16%) 12.78K to 10.78K	0	0	--	--	Show Txns Hide Txns

23-Aug-23 7:31 PM View:	21-Aug-23 Private Sale (Planned) ($289.97K)	Schneyer Mark C. EVP, Chief Financial Officer		Acadia Pharmaceuticals Inc. - ACAD	(39%) 25.68K to 15.68K	0	0	--	--	Show Txns Hide Txns